Drug details
Xyntha (antihemophilic factor)
type of Hemostatics, Coagulation Factors
Xyntha [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free] is a recombinant coagulation factor VIII used to control and prevent bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia). Xyntha does not treat von Willebrand's disease.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- itching,
- rash,
- fever,
- pale skin,
- lightheadedness,
- fast heartbeats,
- numbness,
- tingling,
- dizziness,
- wheezing,
- fainting,
- chest tightness,
- cold sweat,
- increased bleeding episodes,
- any bleeding that will not stop, and
- chest pain
The following drugs are related to Xyntha, either as a replacement or used together:
- Adynovate (antihemophilic factor (recombinant), pegylated for injection)
- Altuviiio (antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl)
- Kogenate FS (antihemophilic factor (recombinant))
- Novoeight (antihemophilic factor (recombinant) lyophilized powder for intravenous injection)
- Eloctate (antihemophilic factor (recombinant), fc fusion protein for intravenous infusion)
- Jivi (antihemophilic factor (recombinant), pegylated-aucl for injection)
- Coagadex (coagulation factor x lyophilized powder)
- Rixubis (coagulation factor ix (recombinant) for intramuscular injection)
- Sevenfact (coagulation factor viia (recombinant)-jncw for injection)
- Stimate (desmopressin acetate nasal spray)
- Esperoct ([antihemophilic factor (recombinant), glycopegylated-exei] injection)
- Hemgenix (etranacogene dezaparvovec-drlb suspension for iv infusion)
- Roctavian (valoctocogene roxaparvovec-rvox suspension)